Pancreatic Cancer Market Size

  • Report ID: 5299
  • Published Date: May 06, 2025
  • Report Format: PDF, PPT

Global Pancreatic Cancer Market Size, Forecast, and Trend Highlights Over 2025-2037

Pancreatic Cancer Market size was over USD 2.48 billion in 2024 and is anticipated to reach USD 13.01 billion by the end of 2037, growing at around 13.6% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of pancreatic cancer is estimated at USD 2.72 billion. 

The growth in the market is majorly attributed to the rising prevalence of associated malignancies across the world. According to a 2023 NLM article, the worldwide incidence of this carcinoma was 4.9 per 100,000, while having a mortality/incidence ratio of 94.0%. It also mentioned that the maximum annual new onsets were observed among people aged over 70 and between 50 and 69. On the other hand, WHO projected the global population of the age group of 60 and over to surpass 2.1 billion by 2050. Another estimation from the Journal of Gastrointestinal Oncology, released in July 2021, revealed that the number of new incidences of pancreatic cancer (PC) around the globe was 400,000 per year. This demographic represents a growing consumer base in this field.

Several studies have proven the importance of early detection to attain the best outcomes from the use of therapies available in the market. In support of this fact, in June 2021, a cost-effectiveness trial on risk-based PC screening in patients with new-onset diabetes (NOD) was published by the National Comprehensive Cancer Network. It presented a base case cost of USD 63,063.0 per quality-adjusted life years (QALY) gained, establishing this method of screen detection to be a cost-effective option for U.S. residents. Furthermore, dedicated companies are continuously investing in R&D to develop long-acting and safer therapeutics with affordable payers’ pricing to improve public access to advanced treatment.


Pancreatic Cancer Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Currently in 2025, the industry revenue of pancreatic cancer is evaluated at USD 2.72 billion.

The global pancreatic cancer market is set to rise from USD 2.48 billion in 2024 to USD 13.01 billion by 2037, exhibiting a CAGR of more than 13.6% during the forecast timeline, between 2025 and 2037.

North America industry is estimated to hold largest revenue share of 32% by 2037, owing to increasing adoption of new technologies for the treatment of cancer cases in the region.

The major players in the market include Amgen Inc., Novartis AG Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., NewLink Genetics Corp, Infinity Pharmaceuticals, Inc., and Celgene Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos